From “Botox in a bottle” to castor oil and face taping, Dermatology Times reviews the evidence behind 3 viral dermatology trends from October.
|Articles|March 6, 2019
- Dermatology Times, March 2019 (Vol. 40, No. 3)
- Volume 40
- Issue 3
Energy-based device facial rejuvenation options
Author(s)Lisette Hilton
From lasers to light therapy to non-laser-based thermal tightening, learn each devices' indications, adverse effects and important treatment takeaways.
Advertisement
In this table, from the March issue of Dermatology Times, we offer a breakdown of the energy-based devices options available for facial rejuvenation treatments. From lasers to light therapy to non-laser-based thermal tightening, learn each devices indications, adverse effects and important treatment takeaways.
Articles in this issue
over 7 years ago
Retired Mayo Clinic Dermatology Chair dies at age 82over 7 years ago
Consumer survey ranks top non-surgical aesthetic proceduresover 7 years ago
RT002 performs well in late-phase studyover 7 years ago
Dermatology department renamed to recognize Dr. Phillip Frostover 7 years ago
Selling cosmeceuticals onlineover 7 years ago
Dermoscopy: The dermatologist’s stethoscopeover 7 years ago
Sustaining a socioeconomically inclusive dermatology practiceover 7 years ago
Novel dermatology drugs approved in 2018over 7 years ago
Increasing skin water content and moisturizationAdvertisement
Related to this article
Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of October.
Face taping promises smoother skin and fewer wrinkles without injectables, but evidence suggests any visible benefits are largely temporary.
Explore trending plant oils in skincare and haircare, plus 2026’s hottest actives like ectoin and hypochlorous acid—balancing glow, barrier repair, and irritation risks.
Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Dermatology PAs unpack 4 frightening skin care myths and trends, from sunscreen misinformation and citrus DIYs to overusing actives and beef tallow.
The approval expands the IL-23 inhibitor’s indications beyond moderate-to-severe plaque psoriasis to include adults with active psoriatic arthritis.
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Tildrakizumab for Active Psoriatic Arthritis
2
FAQ: Remibrutinib (Rhapsido) Becomes First FDA-Approved Treatment for a Chronic Inducible Urticaria
3
Improving Early Identification and Escalation of HS
4
How Approvals, Setbacks, and a Crowded Pipeline Are Reshaping the AD Treatment Landscape
5